A controlled investigation of the cause of chronic idiopathic axonal polyneuropathy

被引:132
作者
Hughes, RAC [1 ]
Umapathi, T
Gray, IA
Gregson, NA
Noori, M
Pannala, AS
Proteggente, A
Swan, AV
机构
[1] Kings Coll London, Guys Kings & St Thomas Sch Med, Dept Clin Neurosci, London SE1 1UL, England
[2] Kings Coll London, Wolfson Ctr Age Related Dis, Sch Biomed Sci, London SE1 1UL, England
关键词
chronic idiopathic axonal polyneuropathy; diabetes mellitus; hypertriglyceridaemia; toxin;
D O I
10.1093/brain/awh192
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
To investigate the aetiology of chronic idiopathic axonal polyneuropathy (CIAP), 50 consecutive patients were compared with 50 control subjects from the same region. There were 22 patients with painful neuropathy and 28 without pain, 26 with sensory neuropathy and 24 with sensory and motor neuropathy. The typical picture was a gradually progressive sensory or sensory and motor neuropathy. It caused mild or sometimes moderate disability, and. reduced the quality of life. There was no evidence that alcohol, venous insufficiency, arterial disease or antibodies to peripheral nerve antigens played a significant part. There was a possible history of peripheral neuropathy in the first or second-degree relatives of six patients and no controls (P=0.01), and claw toes were present in 12 patients and four controls (P=0.03). Thirty-two per cent of the patients and 14% of the controls had impaired glucose tolerance or fasting hyperglycaemia but, after adjusting for age and sex, the difference was not significant (P=0.45), even in the painful neuropathy subgroup. The mean (SD) fasting insulin concentrations were significantly (P=0.01) higher in the patients [75.9 (44.4) mmol/l] than the controls [47.3 (37.9) mmol/l], and the mean was higher still in the painful neuropathy subgroup [92.2 (37.1) mmol/l] (P<0.0001). However, insulin resistance as assessed using the homeostasis model assessment formula was not significantly greater in the patients, even in those with pain, than the controls. After adjustment for body mass index as well as age and sex, there was no significant difference in the serum cholesterol concentrations, but there were significantly higher triglyceride concentrations in the patients [mean 1.90 (1.41) mmol/l] than the controls [mean 1.25 (0.79] mmol/l) (P=0.02). In the patients with painful peripheral neuropathy, the mean triglyceride concentration was 2.37 (1.72), which was even more significantly greater compared with the controls (P=0.003). In conclusion, CIAP is a heterogeneous condition. A logistic regression analysis identified environmental toxin exposure and hypertriglyceridaemia, but not glucose intolerance or alcohol overuse as significant risk factors that deserve further investigation as possible causes of CIAP.
引用
收藏
页码:1723 / 1730
页数:8
相关论文
共 42 条
  • [1] Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO
  • [2] 2-S
  • [3] Australian Bureau of Statistics, 1997, NAT HLTH SURV SF36 P
  • [4] CHRONIC RELAPSING AXONAL NEUROPATHY - A FIRST CASE-REPORT
    CHRONI, E
    HALL, SM
    HUGHES, RAC
    [J]. ANNALS OF NEUROLOGY, 1995, 37 (01) : 112 - 115
  • [5] *COMM TOX CHEM FOO, 1999, CONS PROD ENV ORG
  • [6] DEUTSCH MJ, 1965, J ASSOC OFF AGR CHEM, V48, P1248
  • [7] INTENSIVE EVALUATION OF REFERRED UNCLASSIFIED NEUROPATHIES YIELDS IMPROVED DIAGNOSIS
    DYCK, PJ
    OVIATT, KF
    LAMBERT, EH
    [J]. ANNALS OF NEUROLOGY, 1981, 10 (03) : 222 - 226
  • [8] Multiple sclerosis - Neurofilament light chain antibodies are correlated to cerebral atrophy
    Eikelenboom, MJ
    Petzold, A
    Lazeron, RHC
    Silber, E
    Sharief, M
    Thompson, EJ
    Barkhof, F
    Giovannoni, G
    Polman, CH
    Uitdehaag, BMJ
    [J]. NEUROLOGY, 2003, 60 (02) : 219 - 223
  • [9] LATE-LIFE CHRONIC PERIPHERAL NEUROPATHY OF OBSCURE NATURE
    FISHER, CM
    [J]. ARCHIVES OF NEUROLOGY, 1982, 39 (04) : 234 - 235
  • [10] Reactivity of serum IgG anti-GM1 ganglioside antibodies with the lipopolysaccharide fractions of Campylobacter jejuni isolates from patients with Guillain-Barre syndrome (GBS)
    Gregson, NA
    Rees, JH
    Hughes, RAC
    [J]. JOURNAL OF NEUROIMMUNOLOGY, 1997, 73 (1-2) : 28 - 36